Psychedelic Medicine Assoc: October webinar, Navigating Legal Boundaries: Discussing and Referring Patients to Psychedelic Therapies | Cannabis Law Report | How to buy Skittles Moonrock online
Learn how to buy marijuana online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
Our October webinar, Navigating Legal Boundaries: Discussing and Referring Patients to Psychedelic Therapies, is happening this Thursday, October 24th! This webinar is open to public attendance.
Register: https://lnkd.in/gB-hvmXM
The availability of psychedelic medicine varies widely depending on what country, state, and city a patient lives in—and so as practitioners, it can be difficult to know what’s legally available when evaluating which therapeutics may benefit your patients.
What makes things even more confusing is that for the widely available legal psychedelics, namely ketamine, there are no currently established standards for whether ketamine treatments should include a therapeutic component, and, if so, what certification that therapist should have.
So you may have questions, like, “How can I legally discuss potentially illegal substances with my patients?” and “How can I refer to a ketamine clinic or a clinical trial and protect both my patient and myself?”
This month we are truly fortunate to have three attorneys who are well-versed in these areas to help answer some of your pressing legal questions, including:
• Whether is it legal to discuss psychedelic medicines with patients if those substances are currently illegal
• Whether referring to off-label therapies puts you in any legal danger
• How to best protect yourself from malpractice claims when discussing and referring to psychedelic therapeutics
…and much more!
Panelists joining for this event are:
Kimberly Chew, Esq. | Senior Counsel, Husch Blackwell; Co-Founder & Co-Lead, Psychedelic and Emerging Therapies Practice Group
Karen Luong, Esq. | Partner, Husch Blackwell; Co-Founder & Co-Lead, Psychedelic and Emerging Therapies Practice Group
Natasha Sumner, Esq. | Senior Counsel, Husch Blackwell; Co-Founder & Co-Lead, Psychedelic and Emerging Therapies Practice Group
As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, October 24th at 5 pm Pacific, 8 pm Eastern!
Leave a Reply
Want to join the discussion?Feel free to contribute!